InvestorsHub Logo
Followers 4
Posts 1510
Boards Moderated 0
Alias Born 08/23/2010

Re: None

Thursday, 08/20/2015 9:55:56 PM

Thursday, August 20, 2015 9:55:56 PM

Post# of 13735
Regarding trials and efficacy: Study presented in Barcelona Spain at EASD (European Association for Study of Diabetes) 98 patients, 12 weeks, decreased Hemoglobin A1C and visceral belly fat, no reported side effects. For any that are interested, google "EASD and Sucanon" to see the news release. Abstract from the meeting was released at the time as well.